Cerebrospinal fluid levels of the soluble amyloid precursor protein in patients 
with mild cognitive impairment and different forms of dementia: a diagnostic 
marker

Post, A; Ackl, N; Schreiber, Y; Rücker, M; Sonntag, A; Holsboer, F; Almeida, OFX

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Cerebrospinal fluid levels of the soluble amyloid precursor protein in patients with mild cognitive impairment and different forms of dementia: a diagnostic marker

MPS-Authors

Post, A
Max Planck Institute of Psychiatry, Max Planck Society;

Ackl, N
Max Planck Institute of Psychiatry, Max Planck Society;

Schreiber, Y
Max Planck Institute of Psychiatry, Max Planck Society;

Rücker, M
Max Planck Institute of Psychiatry, Max Planck Society;

Sonntag, A
Max Planck Institute of Psychiatry, Max Planck Society;

Holsboer, F
Max Planck Institute of Psychiatry, Max Planck Society;

Almeida, OFX
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Post, A., Ackl, N., Schreiber, Y., Rücker, M., Sonntag, A., Holsboer, F., et al. (2002). Cerebrospinal fluid levels of the soluble amyloid precursor protein in patients with mild cognitive impairment and different forms of dementia: a diagnostic marker. Pharmacopsychiatry, 35(5), XVI-XVI.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-A165-D

Abstract

There is no abstract available